| Abstrakt: |
A recent study from Boise State University explores the role of nicotinamide adenine dinucleotide+ (NAD+) and NAD+-boosting therapies in the inflammatory response by IL-13. NAD+ is known for its role in redox reactions during oxidative respiration, but its functions in other processes are still being discovered. Maintaining NAD+ levels through diet is important for overall health, and increasing NAD+ levels has been found to be beneficial for conditions such as cancer, cardiovascular health, inflammatory response, and longevity. The study presents evidence suggesting that increasing NAD+ levels may reduce IL-13 signal-induced inflammatory response and discusses the use of NAD+ precursor compounds for this purpose. [Extracted from the article] |
